Cofibrins and Fibrin-Intermediates as Indicators of Thrombin Activity in Vivo

Author:

SHAINOFF JOHN R.1,PAGE IRVINE H.1,Andrasi Miss Dolores1

Affiliation:

1. Research Division of the Cleveland Clinic Foundation and the Frank E. Bunts Educational Institute, Cleveland, Ohio

Abstract

A cold-precipitable, thrombin-coagulable protein, tentatively designated "cryoprofibrin," was separated from plasma of rabbits treated with E. coli endotoxin. It was shown to contain fibrin-intermediates, consisting of fibrinogen that has lost only a portion of the peptides liberated during the conversion of rabbit fibrinogen to fibrin. These peptides have been called cofibrins. On reaction with thrombin, fibrinogen and cryoprofibrin yielded the same amount of cofibrin B (0.9 moles per 220,000 Gm. of fibrin clot); however, cryoprofibrin yielded 30 per cent less cofibrin A than did fibrinogen. Cryoprofibrin and fibrinogen yielded 0.7 and 1.0 moles of cofibrin A per 220,000 Gm. of fibrin, respectively. The deficit of cofibrin A in preference to cofibrin B provides evidence that, cryoprofibrin consists of fibrinogen that had lost cofibrin A by limited action of thrombin, because cofibrin A is liberated from fibrinogen by thrombin more rapidly than is cofibrin B. Only a small portion of the cryoprofibrin could have been produced by action of thrombin subsequent to exsanguination, because the plasma contained only about one-third of the cofibrin A that had been liberated from fibrin-ogen during its conversion to cryoprofibrin. Accordingly, cryoprofibrin provides a valid measure of thrombin activity in vivo, at least in the endotoxin-treated rabbits. An alternative approach to measurement of thrombin activity involving recovery of cofibrin A from urine proved inapplicable, because no confibrin A was found to be excreted in urine. An average of 0.264 ± 0.038 mg. cryoprofibrin per ml. was obtained from plasma of treated rabbits, as compared with 0.044 ± 0.016 mg. of cold-precipitable fibrinogen per ml. of normal plasma. The demonstration of increased thrombin activity after endotoxin treatment, as evidenced by the cryoprofibrin, implicates thrombin in the mechanism of fibrinoid deposition. The demonstration that cryoprofibrin consists of fibrin-intermediates supports Thomas' hypothesis that fibrinoid consists of fibrin-intermediates.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Physiology

Reference25 articles.

1. BAILEY K. BETTELHEIM F. B. LORAND L. AND MIDDLEBROOK W. B.: Action of thrombin in clotting of fibrinogen. Nature 167: 233 1951.

2. Thrombin-induced formation of cofibrin. I. Isolation, purification, and characterization of co-fibrin;GLADNER J. A.;J. Biol. Chem.,1959

3. Conjugated nonprotein, amino acids of plasma. Peptidemia and hyperpeptiduria as result of intravenous administration of partially hydrolyzed casein (amigen);CHRISTENSEN H. N.;J. Biol. Chem.,1946

4. BETTELHEIM F. R.: Clotting of fibrinogen. II. Fractionation of peptide material liberated. Biochim. et biophys. acta 19: 121 195G.

5. BLOMBACK B. AND VESTERMARK A.: Isolation of fibrinopeptides by chromatograpliy. Arkiv fiir kemi 12: 173 1958.

Cited by 154 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3